Financial report interval: 2026.03.30 - 2026.06.30
Overview: Bristol-Myers Squibb Company(CELG.RT) the Revenue is 12.97 B (+5.74%), Beat estimate;the EBIT is 5.12 B (+48.36%), Beat estimate.